Acro Biomedical (ACBM) Cash & Equivalents (2015 - 2025)
Acro Biomedical (ACBM) recorded quarterly Cash & Equivalents of $4098.0 in Q4 2025, down 5.2% quarter-over-quarter from $4323.0 in Q3 2025, and up 760.92% on a YoY basis from $476.0 in Q4 2024.
Acro Biomedical (ACBM) Cash & Equivalents (2015 - 2025) Analysis & Trends
Acro Biomedical's Cash & Equivalents history runs 11 years deep, the most recent figure standing at $4098.0 for Q4 2025.
- In Q4 2025, Cash & Equivalents rose 760.92% year-over-year to $4098.0; the TTM figure through Dec 2025 stood at $4098.0 (up 760.92% YoY), while the FY2025 annual figure was $4098.0, up 760.92% from the prior year.
- Cash & Equivalents was $4098.0 for Q4 2025 at Acro Biomedical, down from $4323.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $357668.0 in Q1 2022 to a low of $26.0 in Q2 2025.
- Historically, Cash & Equivalents has averaged $44959.0 across 5 years, with a median of $3684.5 in 2023.
- The sharpest annual moves came in 2021 and 2023: Cash & Equivalents jumped 99042.95% in 2021, then tumbled 99.91% in 2023.
- A 5-year view of Cash & Equivalents shows it stood at $95248.0 in 2021, then tumbled by 93.86% to $5852.0 in 2022, then sank by 93.57% to $376.0 in 2023, then increased by 26.6% to $476.0 in 2024, then surged by 760.92% to $4098.0 in 2025.
- The last three Cash & Equivalents figures came in at $4098.0 (Q4 2025), $4323.0 (Q3 2025), and $26.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | 1.47 Mn |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | 112,660.00 |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | 209,016.00 |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 167,798.00 |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | 28,828.00 |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 553,972.00 |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | 1.00 |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | 521,352.00 |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | 1.12 Mn |
| 10 | Acro Biomedical | - | - | - | 4,098.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,098.00 |
| Sep 30, 2025 | 4,323.00 |
| Jun 30, 2025 | 26.00 |
| Mar 31, 2025 | 251.00 |
| Dec 31, 2024 | 476.00 |
| Sep 30, 2024 | 701.00 |
| Jun 30, 2024 | 926.00 |
| Mar 31, 2024 | 151.00 |
| Dec 31, 2023 | 376.00 |
| Sep 30, 2023 | 3,271.00 |
| Jun 30, 2023 | 2,680.00 |
| Mar 31, 2023 | 322.00 |
| Dec 31, 2022 | 5,852.00 |
| Sep 30, 2022 | 16,188.00 |
| Jun 30, 2022 | 12,107.00 |
| Mar 31, 2022 | 357,668.00 |
| Dec 31, 2021 | 95,248.00 |
| Sep 30, 2021 | 154,663.00 |
| Jun 30, 2021 | 215,494.00 |
| Mar 31, 2021 | 24,359.00 |